Catalent Inc.



+36.9% (1 year change)

Market Cap

$22.2 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$91.87 - $142.64

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $22.2 Billion
Enterprise Value $24.5 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +36.9%
52-Week High $142.64
52-Week Low $91.87
Beta 1.03
Outstanding Shares 171 Million
Avg 30 Day Volume 1.01 Million


P/E Ratio 40.76
PEG 184.51
Earnings per Share $3.18
Price to Sales Ratio 5.3
Price to Book Ratio 5.09
Revenue to Enterprise Value 5.86
EBIT to Enterprise Value 35.02
Total Debt to Enterprise Value 0.18
Debt to Equity 0.98


Revenue $4.18 Billion
Gross Profit $1.43 Billion
EBIT $699 Million
Net Income $544 Million
Profit Margin 13.03%
Quarterly Earnings Growth (YoY) +22.1%
Return on Equity 12.42%
Return on Assets 5.34%
Return on Invested Capital 7.69%

Insider trades

No purchases

51,291 shares sold (17 transactions)

No purchases

2,800 shares sold (1 transactions)

No purchases

1,187 shares sold (1 transactions)

No purchases

37,518 shares sold (7 transactions)

Q1 2021 Q2 2021 Q3 2021 Q4 2021

Similar stocks

Supernus Pharmaceuticals Inc
Aerie Pharmaceuticals Inc
Jazz Pharmaceuticals plc
Intercept Pharmaceuticals Inc